Dr. Mohammed M. Dallal, M.D.
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 41
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 817
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
OH license 35067761 -
Critical Care Medicine (Internal Medicine) Physician
OH license 35067761 -
Sleep Medicine (Internal Medicine) Physician
OH license 35067761
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Miami Valley Hospital Dayton, OH
- Kettering Health Main Campus Kettering, OH
- Upper Valley Medical Center Troy, OH
- Atrium Medical Center Franklin, OH
- Wayne Hospital Greenville, OH
Medical groups
- Pulmonary and Critical Care Consultants, Inc (36 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 817
- Services billed
- 2,095
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 474 | 368 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 258 | 139 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 227 | 118 |
| Established patient office or other outpatient visit, 30-39 minutes | 207 | 127 |
| Critical care, first 30-74 minutes | 137 | 64 |
| Test to measure expiratory airflow and volume | 58 | 49 |
| Test to examine how well the lungs exchange gases | 56 | 49 |
| X-ray of chest, 2 views | 56 | 46 |
| New patient office or other outpatient visit, 30-44 minutes | 53 | 53 |
| Test to determine lung volumes using sensors | 52 | 46 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Dayton, OH | 437 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Dayton, OH | 195 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Dayton, OH | 151 |
| Prednisone Other prescribers in Dayton, OH | 96 |
| Azithromycin Other prescribers in Dayton, OH | 94 |
| Fluticasone Propionate Other prescribers in Dayton, OH | 86 |
| Fluticasone-Salmeterol (fluticasone propion/salmeterol) Other prescribers in Dayton, OH | 84 |
| Advair Hfa (fluticasone propion/salmeterol) Other prescribers in Dayton, OH | 84 |
| Budesonide-Formoterol Fumarate (budesonide/formoterol fumarate) Other prescribers in Dayton, OH | 79 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Dayton, OH | 71 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 34 payments worth $755 in total to this clinician.
| Genzyme Corporation | $176 |
|---|---|
| Pulmonx Corporation | $123 |
| Inspire Medical Systems, Inc. | $86.45 |
| Regeneron Healthcare Solutions, Inc. | $64.77 |
| Jazz Pharmaceuticals Inc. | $61.54 |
| GlaxoSmithKline, LLC. | $57.99 |
| Verona Pharma, Inc. | $42.72 |
| Zoll Respicardia, Inc. | $32.94 |
| Food and Beverage | $738 |
|---|---|
| Education | $17.38 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Insmed, Inc. Sep 17, 2025 | Education Brinsupri; Brinsupri · Respiratory · in-kind | $17.38 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.